The combined effect of BCL-2 over-expression and E2F2 deficiency induces an autoimmune syndrome in non-susceptible mouse strain C57BL/6

Autoimmunity

Volumn 43, Issue 2, 2010, Pages 111-120

  Marín Vidalled, María José ^a   Bolívar, Ainhoa ^a   Zubiaga, Ana ^b   López Hoyos, Marcos ^a  

^a Santa Cruz de Liendres Hospital   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Apoptosis; Autoantibodies; Cell cycle; Glomerulonephritis; Mice

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN BCL 2; SINGLE STRANDED DNA; TRANSCRIPTION FACTOR E2F2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AXILLARY LYMPH NODE; B LYMPHOCYTE; BONE MARROW CELL; C57BL 6 MOUSE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; HETEROZYGOTE; HISTOPATHOLOGY; HOMEOSTASIS; IMMUNOFLUORESCENCE; INGUINAL LYMPH NODE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOID CELL; MESANGIUM; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN INDUCTION; SEROLOGY; WILD TYPE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL COUNT; CELL CYCLE; CELL SEPARATION; E2F2 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; GENES, BCL-2; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; SYNDROME; UP-REGULATION;

EID: 77649331395     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916930903214033     Document Type: Article

References (38)

1. Strasser A, Whittingam S, Vaux DL, Bath ML, Adams JM, Cory S, Harris A. Enforced bcl-2 expression in B-cells prolongs antibody response and elicit autoimmune disease. Proc Nat Acad Sci USA 1991;88:8661-8665.
2. Watanabe-Fukunaga R, Brannan CL, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferatives disorder in mice explained by defect in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
3. Garcia I, Murga M, Vicario A, Field SJ, Zubiaga A. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ 2000;11:91-98.
4. Santiago-Raber MI, Lawson BR, Dummer W, Barnhouse M, Koundouris S, et al. Role of cyclin kinase inhibitor p21 in autoimmunity. J Inmmunol 2001;167:4067-4074.
5. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini VE, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev 2001;15:267-285.
6. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarrays analysis. Mol Cell Biol 2001;21:4684-4699.
7. Polager S, Kalma Y, Berkovich E, Ginsberg D. E2F up-regulates expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002;17:437-446.
8. Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Fields SJ, Real FX, Zubiaga AM. Diabetes and a exocrine pancreatic insufficiency in E2F1/ E2F2 double mutant mice. J Clin Invest 2004;113: 1398-1407.
9. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev 2002; 15:245-265.
10. Attwooll C, Denchi EL, Helin K. The E2F family: Specific functions and overlapping interest. EMBO J 2004;23: 4709-4723.
11. Johnson D, Schwartz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature 1993;365:349-352. (Pubitemid 23288977)
12. Lukas J, Petersen BO, Holm K, Bartek J, Helin K. Deregulated expression of E2F members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 1996;16:1047-1057.
13. Murga M, Fernandez-Capetillo O, Field SJ, Moreno B, Borlado L, Fujiwara Y, Balomenos D, Carrera A, Orkin S, Zubiaga A. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the develpment of autoimmunity. Immunity 2001;15:959-970.
14. Infante A, Laresgoiti U, Fernandez Rueda J, Fullaondo A, Galán J,D?́az Uriarte R, Malumbres R, Field SJ, Zubiaga AM. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle 2008;7:3915-3927.
15. Vairo G, Innes KM, Adams JM. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 1996;13:1511-1519.
16. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer TJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-3610.
17. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
18. McDonnell TJ, Deane N, Platt FM, Nuñez G, Jaeger U, McKearn JP, Korsmeyer SJ. Bcl-2 inmunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
19. Strasser A, Harris AW, Cory S. The role of Bcl-2 in lymphoid differentiation and neoplastic transformation. Curr Top Microbiol Immunol 1992;182:299-302.
20. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC. Elimination of self reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 1993;72:325-335.
21. Marquina R, Diez MA, López-Hoyos M, Buelta L, Kuroki S, Villegas J, Pihlgren M, Siegrist C, Arias M. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zeland White(C57BL/6) F(1)-bcl-2 transgenic mice. J Immunol 2004;172:7177-7185.
22. López HoyosM, Carrió R, Merino R, Buelta L, Izui S, Nuñez G, Merino J. Constitutive expression of Bcl-2 in B cells causes lethal formof lupus-like autoimmune disease after induction of neonatal tolerance to H-2b alloantigens. J Exp Med 1996;183: 2523-2531.
23. Carlucci F, Cortes-Hernandez J, Fossati-Jimark L, Bygrave A, WalportM, Vyse T, Cook HT, Botto M. Genetic dissection of spontaneus autoimmunity driven by 129-derived chromosome 1 loci when expressed on C57BL/6 mice. J Inmmunol 2007; 178:2352-2360.
24. Fossati-Jimack L, Cortes-Hernandez J, Norsworthy PJ, Cook HT, Walpot MJ, Botto M. Regulation of B cell-tolerance by 129-derived chromosome 1 loci in C57BL/6. Arthritis Rheum 2008;58:1231-1241.
25. Obara T, Tanaka T, Stockert E, Good RA. Autoimmune and lymphoproliferatives diseases in (B6-GIX(129) F1: Relation to naturally occurring antibodies against murine leukaemia virusrelated surface antigen. Proc Natl Acad Sci USA 1979;76: 5289-5293.
26. Santiago-Raber ML, Laporte C, Reininger L, Izui S. Genetic basis of murine lupus. Autoimmun Rev 2004;3:33-39.
27. Mitchell DA, Pickering MC, Warrening J, Fossati-Jimark L, Cortes-Hernandez J, et al. C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J Inmmunol 2002;168:2538-2543.
28. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, Martinez AC. The cell cycle inmhibitor p21 control T proliferation and sex-linked lupus development. Nat Med 2000;6:171-176.
29. Morel L. Mouse models of autoimmune disease: Essential tools that require the proper controls. PLOS Biol 2004;2(8): e224.
30. Heidari Y, Fossati-Jimack L, Carlucci F, Walport MJ, Cook HT, Botto M. A lupus-succeptibility C57BL/6 lucus on chromosome 3 (Sle18) contributes to autoantibodies production in 129 mice. Genes Immune 2009;10:47-55.
31. Bouillet P, Purton JF, Godfrey DI, Zhang L-C, Puthalakath H, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactives thymocytes. Nature 2002;415: 922-926.
32. Salvador JM, Hollander C, Thu Nguyen A, Kopp J, Barisoni L, Moore JK, Ashwell J, Fornace AJ Jr. Mice lacking the p53- effector gene Gadd45a develop a lupus-like syndrome. Immunity 2002;16:499-508.
33. Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM. Bcl-2 retards cell cycle entry through p27 (Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol 2000;20:4745-4753.
34. Strasser A, Harris AW, Cory S. E mu-Bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cell, but not T cells. Oncogene 1993;8:1-9.
35. Phillips AC, Vousden KH. E2F1 induced apoptosis. Apoptosis 2001;6:173-182.
36. Li Q, Dashwood WM, Nakagama H, Zhong X, Dashwood RH. Bcl-2 overexpression in PhIP-induced colon tumors: Cloning the rat Bcl-2 promoter and characterization of a pathway involving b-catenin, c-Myc and E2F1. Oncogene 2007;26:6194-7202.
37. Diriam A, Spike BT, Macleod KF. Deregulated E2F2 underlies cell cycle and maturation defects in retinoblastoma null erytroblasts. Mol Cell Biol 2007;27:8713-8728.
38. Li FX, Zhu JW, Hogan CJ, DeGregori J. Defective gene expression, S phase progession, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Moll Cell Biol 2003;23:3607-3622.